Live Quote · NASDAQACTUHealthcare· Biotechnology

Actuate Therapeutics Inc

$0.23▲ 5.38%(+$0.01)
MKT CAP $5.41MNEXT EARNINGS Mar 25, 2027
50%
Bullish
TickerSpark Score
56/100
▌ Mixed
100
Valuation
40
Profitability
60
Growth
52
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACTU research report →

Analyst Price Target
$21.00+9220.9% vs. today

Range $21 – $21

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-96.35% · this period
$7.63$3.92$0.21Nov 19May 22Nov 19
52-Week Range1% of range
Low
$0.17
Current
$0.23
High
$7.90